Author Correction: Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab

Detalles Bibliográficos
Autores principales: Spindeldreher, Sebastian, Maillère, Bernard, Correia, Evelyne, Tenon, Maxime, Karle, Anette, Jarvis, Philip, Kolbinger, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Author Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002311/
https://www.ncbi.nlm.nih.gov/pubmed/29551008
http://dx.doi.org/10.1007/s13555-018-0234-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002311/
https://www.ncbi.nlm.nih.gov/pubmed/29551008
http://dx.doi.org/10.1007/s13555-018-0234-5

Ejemplares similares